✦ LIBER ✦

A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors

✍ Scribed by Patnaik, Amita; LoRusso, Patricia M.; Messersmith, Wells A.; Papadopoulos, Kyriakos P.; Gore, Lia; Beeram, Muralidhar; Ramakrishnan, Vanitha; Kim, Amy H.; Beyer, Joseph C.; Mason Shih, L.; Darbonne, Walter C.; Xin, Yan; Yu, Ron; Xiang, Hong; Brachmann, Rainer K.; Weekes, Colin D.

Book ID: 125344279
Publisher: Springer
Year: 2014
Tongue: English
Weight: 425 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2426-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of the human monoclonal

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

372 A phase I dose-escalation study of t

372 A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors

✍ C. Weekes; P. Hedge; Y. Xin; R. Yu; H. Xiang; L. Gore; M. Beeram; R. Brachmann; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

202 POSTER Mapatumumab, a fully human ag

202 POSTER Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase 1 study in patients with advanced solid malignacies

✍ C.H. Mom; S. Sleijfer; J.A. Gietema; N.L. Fox; C. Piganeau; L. Lo; D.R.A. Uges; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

404 Phase I study of MEDI-575, a fully h

404 Phase I study of MEDI-575, a fully human monoclonal antibody targeting PDGFR-alpha in subjects with advanced solid tumors

✍ R. Lechleider; C. Becerra; M. Liang; R. Narwal; L. Shi; P. Conkling; M. Galsky; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase Ib combination study of RO492909

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

✍ Ivan Diaz-Padilla, Hal Hirte, Amit M. Oza, Blaise A. Clarke, Brenda Cohen, Micha 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 344 KB

367 A first-in-human Phase 1 study of an

367 A first-in-human Phase 1 study of anti-CD105 antibody therapy with TRC105 in patients with advanced solid tumors

✍ L. Rosen; M.S. Gordon; H.I. Hurwitz; M.K. Wong; J. Goldman; B.J. Adams; D. Alvar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB